APPLICATION
NDA006134
TYPE
NDA
ORIGINAL APPROVAL
1947-08-13
LATEST ACTION
2021-06-02
ROUTE
ORAL
DOSAGE FORM
SYRUP, TABLET
MARKETING STATUS
Discontinued
Products
DOLOPHINE HYDROCHLORIDEDiscontinued
METHADONE HYDROCHLORIDE 10MG/30ML · SYRUP · ORAL
DOLOPHINE HYDROCHLORIDE · ReferenceDiscontinued
METHADONE HYDROCHLORIDE 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET · ORAL
DOLOPHINE HYDROCHLORIDE · ReferenceDiscontinued
METHADONE HYDROCHLORIDE 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET · ORAL
Approval history
2000-10-17Labeling · Supplement 23 · standardAP
2000-05-05Manufacturing (CMC) · Supplement 27AP
1999-03-30Manufacturing (CMC) · Supplement 26AP
1999-03-12Labeling · Supplement 17AP
1998-11-12Manufacturing (CMC) · Supplement 25AP
1996-10-15Manufacturing (CMC) · Supplement 24AP
1995-02-21Manufacturing (CMC) · Supplement 22AP
1994-05-11Manufacturing (CMC) · Supplement 21AP
1987-08-13Labeling · Supplement 15AP
1986-01-10Labeling · Supplement 13AP
1981-10-16Manufacturing (CMC) · Supplement 12AP
1980-02-01Manufacturing (CMC) · Supplement 9AP
1977-01-05Labeling · Supplement 8AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.